Cargando…
Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma
BACKGROUND/AIMS: Transarterial chemoembolization (TACE) improves the survival of patients with unresectable hepatocellular carcinoma (HCC) and has been recommended as a first-line therapy for nonsurgical patients with large or multifocal HCC. The long-term outcome of HCC patients receiving TACE prio...
Autores principales: | Kang, Ja Young, Choi, Moon Seok, Kim, Sue Jin, Kil, Jae Sook, Lee, Joon Hyoek, Koh, Kwang Cheol, Paik, Seung Woon, Yoo, Byung Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304614/ https://www.ncbi.nlm.nih.gov/pubmed/21415582 http://dx.doi.org/10.3350/kjhep.2010.16.4.383 |
Ejemplares similares
-
Prediction of Complete Necrosis of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Prior to Liver Transplantation
por: Kim, Sue Jin, et al.
Publicado: (2009) -
Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors
por: Sohn, Won, et al.
Publicado: (2014) -
Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
por: Kim, Jun Young, et al.
Publicado: (2016) -
Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
por: Kim, Jihye, et al.
Publicado: (2019) -
Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial
por: Yu, Jeong Il, et al.
Publicado: (2017)